Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
Authors
Keywords
-
Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 94, Issue 9, Pages 886-894
Publisher
Wiley
Online
2016-06-06
DOI
10.1038/icb.2016.55
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pharmacogenetic study implicatesSLC9a9in multiple sclerosis disease activity
- (2015) Federica Esposito et al. ANNALS OF NEUROLOGY
- Novel therapies for memory cells in autoimmune diseases
- (2015) P. Bhargava et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks
- (2015) Martina Severa et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
- (2015) Ryan D. Schubert et al. JOURNAL OF IMMUNOLOGY
- IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status
- (2015) Martina Severa et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Effect of TACI Signaling on Humoral Immunity and Autoimmune Diseases
- (2015) Yi Zhang et al. Journal of Immunology Research
- The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
- (2014) Franziska S. Hoffmann et al. JOURNAL OF IMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Roles of ligands from the TNF superfamily in B cell development, function, and regulation
- (2014) William A. Figgett et al. SEMINARS IN IMMUNOLOGY
- IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients
- (2013) Elena Giacomini et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death
- (2013) William A. Figgett et al. IMMUNITY
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF
- (2013) E. Y. Abu-Rish et al. RHEUMATOLOGY
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma
- (2012) A. J. De Roos et al. CANCER RESEARCH
- Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
- (2012) E Croze et al. PHARMACOGENOMICS JOURNAL
- Autoimmune disease: A role for new anti-viral therapies?
- (2011) David H. Dreyfus AUTOIMMUNITY REVIEWS
- Treatment of multiple sclerosis with Anti-CD20 antibodies
- (2011) Barbara Barun et al. CLINICAL IMMUNOLOGY
- B cells in multiple sclerosis: connecting the dots
- (2011) H-Christian von Büdingen et al. CURRENT OPINION IN IMMUNOLOGY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation
- (2010) Barbara Serafini et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Regulatory B cells in autoimmunity: developments and controversies
- (2010) Claudia Mauri et al. Nature Reviews Rheumatology
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI
- (2009) R. A. Farrell et al. NEUROLOGY
- Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
- (2008) Samantha Jilek et al. BRAIN
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now